List of Tables
    Table 1. Meningococcal Disease Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Meningococcal Disease Drugs Market Trends
    Table 3. Meningococcal Disease Drugs Market Drivers
    Table 4. Meningococcal Disease Drugs Market Challenges
    Table 5. Meningococcal Disease Drugs Market Restraints
    Table 6. Global Meningococcal Disease Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Meningococcal Disease Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Meningococcal Disease Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Meningococcal Disease Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Meningococcal Disease Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Meningococcal Disease Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Meningococcal Disease Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Meningococcal Disease Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Meningococcal Disease Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Meningococcal Disease Drugs Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Meningococcal Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Meningococcal Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Disease Drugs as of 2021)
    Table 18. Top Players of Meningococcal Disease Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Meningococcal Disease Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Meningococcal Disease Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Meningococcal Disease Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Meningococcal Disease Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Meningococcal Disease Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Meningococcal Disease Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Meningococcal Disease Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Meningococcal Disease Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Meningococcal Disease Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Meningococcal Disease Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Meningococcal Disease Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Meningococcal Disease Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Meningococcal Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Meningococcal Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Meningococcal Disease Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Meningococcal Disease Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Meningococcal Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Meningococcal Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Meningococcal Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Meningococcal Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Meningococcal Disease Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Meningococcal Disease Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Pfizer Meningococcal Disease Drugs Product
    Table 46. Pfizer Recent Development
    Table 47. GlaxoSmithKline Corporation Information
    Table 48. GlaxoSmithKline Description and Business Overview
    Table 49. GlaxoSmithKline Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. GlaxoSmithKline Product
    Table 51. GlaxoSmithKline Recent Development
    Table 52. Sanofi Pasteur Corporation Information
    Table 53. Sanofi Pasteur Description and Business Overview
    Table 54. Sanofi Pasteur Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Sanofi Pasteur Product
    Table 56. Sanofi Pasteur Recent Development
    Table 57. Novartis Corporation Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Novartis Product
    Table 61. Novartis Recent Development
    Table 62. Merck Sharp & Dohme Corporation Information
    Table 63. Merck Sharp & Dohme Description and Business Overview
    Table 64. Merck Sharp & Dohme Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Merck Sharp & Dohme Product
    Table 66. Merck Sharp & Dohme Recent Development
    Table 67. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Corporation Information
    Table 68. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Description and Business Overview
    Table 69. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Product
    Table 71. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Recent Development
    Table 72. Shandong Jincheng Pharmaceutical Group Co.,ltd. Corporation Information
    Table 73. Shandong Jincheng Pharmaceutical Group Co.,ltd. Description and Business Overview
    Table 74. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Shandong Jincheng Pharmaceutical Group Co.,ltd. Product
    Table 76. Shandong Jincheng Pharmaceutical Group Co.,ltd. Recent Development
    Table 77. Apeloa Pharmaceutical Co.,Ltd. Corporation Information
    Table 78. Apeloa Pharmaceutical Co.,Ltd. Description and Business Overview
    Table 79. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Apeloa Pharmaceutical Co.,Ltd. Product
    Table 81. Apeloa Pharmaceutical Co.,Ltd. Recent Development
    Table 82. Yiling Pharmaceutical Corporation Information
    Table 83. Yiling Pharmaceutical Description and Business Overview
    Table 84. Yiling Pharmaceutical Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Yiling Pharmaceutical Product
    Table 86. Yiling Pharmaceutical Recent Development
    Table 87. Baiyunshan Pharmaceutical Corporation Information
    Table 88. Baiyunshan Pharmaceutical Description and Business Overview
    Table 89. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Baiyunshan Pharmaceutical Product
    Table 91. Baiyunshan Pharmaceutical Recent Development
    Table 92. SSY Group Limited Corporation Information
    Table 93. SSY Group Limited Description and Business Overview
    Table 94. SSY Group Limited Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. SSY Group Limited Product
    Table 96. SSY Group Limited Recent Development
    Table 97. Lukang Pharmaceutical Co.,Ltd. Corporation Information
    Table 98. Lukang Pharmaceutical Co.,Ltd. Description and Business Overview
    Table 99. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Lukang Pharmaceutical Co.,Ltd. Product
    Table 101. Lukang Pharmaceutical Co.,Ltd. Recent Development
    Table 102. North China Pharmaceutical Company Ltd. Corporation Information
    Table 103. North China Pharmaceutical Company Ltd. Description and Business Overview
    Table 104. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. North China Pharmaceutical Company Ltd. Product
    Table 106. North China Pharmaceutical Company Ltd. Recent Development
    Table 107. Harbin Pharmaceutical Group Co.,Ltd. Corporation Information
    Table 108. Harbin Pharmaceutical Group Co.,Ltd. Description and Business Overview
    Table 109. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Harbin Pharmaceutical Group Co.,Ltd. Product
    Table 111. Harbin Pharmaceutical Group Co.,Ltd. Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Meningococcal Disease Drugs Customers List
    Table 115. Meningococcal Disease Drugs Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meningococcal Disease Drugs Product Picture
    Figure 2. Global Meningococcal Disease Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Meningococcal Disease Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Meningococcal Disease Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Meningococcal Disease Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Meningococcal Disease Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Meningococcal Disease Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Meningococcal Disease Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Meningococcal Disease Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Meningococcal Disease Drugs Report Years Considered
    Figure 11. Product Picture of Injectable
    Figure 12. Product Picture of Oral
    Figure 13. Global Meningococcal Disease Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Meningococcal Disease Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Meningococcal Disease Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Meningococcal Disease Drugs Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Meningococcal Disease Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Meningococcal Disease Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Meningococcal Disease Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Meningococcal Disease Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Meningococcal Disease Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Meningococcal Disease Drugs Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Meningococcal Disease Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Meningococcal Disease Drugs Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Drugstores
    Figure 27. Product Picture of Others
    Figure 28. Global Meningococcal Disease Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Meningococcal Disease Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Meningococcal Disease Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Meningococcal Disease Drugs Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Meningococcal Disease Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Meningococcal Disease Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Meningococcal Disease Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Meningococcal Disease Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Meningococcal Disease Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Meningococcal Disease Drugs Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Meningococcal Disease Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Meningococcal Disease Drugs Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Meningococcal Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Meningococcal Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Meningococcal Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Meningococcal Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Meningococcal Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Meningococcal Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Meningococcal Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Meningococcal Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Meningococcal Disease Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Meningococcal Disease Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Meningococcal Disease Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Meningococcal Disease Drugs Value Chain
    Figure 73. Meningococcal Disease Drugs Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed